|
RS20110151A2
|
|
Granules with ibuprofen and pseudoephedrine and process for their production
|
|
RS20100436A2
|
|
Autochthonous lactobacillus strains and their use as probiotics
|
|
RS20090393A
|
|
Stabile liquid pharmaceutical formulation
|
|
RS20060371A
|
|
Diclofenac sodium extended-release tablets
|
|
RS20050953A
|
|
Process for preparation of substituted aryloxy -2,3-epoxypropane
|
|
RS116204A
|
|
Antacide agent
|
|
RS44604A
|
|
Controlled-release carbamazepine two-layer tablets
|
|
YU804A
|
|
Synthesis of novel 4'-c-hydroxymethyl nucleosides
|
|
YU72003A
|
|
Bufferred tablets having acetylsalicylic acid
|
|
YU66903A
|
|
Enterosolvent tablets with acetylsalicylic acid
|
|
YU64603A
|
|
Swelling erodible matrix system with controlled active substance release
|
|
YU17703A
|
|
New pharmaceutical composition for use on skin
|
|
YU14403A
|
|
New use of compounds
|
|
YU99402A
|
|
Instant drinks and procedures for production thereof
|
|
YU99302A
|
|
New thioribose derivatives
|
|
YU92502A
|
|
New pharmaceutical preparation in the form of ointment and its preparation procedure
|
|
YU84902A
|
|
Mineral-vitamine pharmaceutical products based on yeast
|
|
YU81002A
|
|
Glinkosides of thiazofurine
|
|
YU70799A
|
|
Derivatives of tiazofurin
|
|
YU51297A
|
|
Preparation procedure for obtaining bovine insulin micro- crystals with delayed release
|
